CORCEPT THERAPEUTICS INC — Director's Dealing 2021

Sep 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2021-09-13

Reporting Person: Robb Gary Charles (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-13	Common Stock	S	6341	$20.8871	Disposed	136507	Direct
2021-09-14	Common Stock	S	806	$20.7639	Disposed	135701	Direct
2021-09-15	Common Stock	S	47853	$20.4949	Disposed	87848	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4564	Indirect
Common Stock	4564	Indirect
Common Stock	4564	Indirect

Footnotes

F1: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.88 to $20.905. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.76 to $20.88. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F3: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.405 to $20.58. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F4: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.